Brief introduction of Yangzhou Yiyang pharmaceutical co., ltd

The total investment scale of the enterprise is US$ 6.25 million, of which the investment ratio of South Korea Yiyang Pharmaceutical and Gaoyou Industrial Corporation is 52: 48.

This company is the second Korean-funded pharmaceutical enterprise in Jiangsu Province, and the first one passed the national GMP. With a high GMP awareness and strict internal norms and quality control, the employees of the company produce Yangzhou Yiyang products in a clean and hygienic environment, which are completely responsible for the health and happiness of consumers.

At present, the products produced by the company, such as antipyretic injection, Ashagir injection, gastric mucosal protective agent for hyperacidity, aluminum-magnesium suspension, snake bile digestion tablets and self-developed gliclazide, are sold all over the country, with a high growth rate of more than 50% every year.